BIOL Stock Summary and Trading Ideas (Biolase | NASDAQ:BIOL)

Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.

Biolase trades on the NASDAQ stock market under the symbol BIOL.

As of April 19, 2024, BIOL stock price declined to $0.14 with 1,260,998 million shares trading.

BIOL has a beta of 1.57, meaning it tends to be more sensitive to market movements. BIOL has a correlation of 0.01 to the broad based SPY ETF.

BIOL has a market cap of $4.52 million. This is considered a Sub-Micro Cap stock.

Last quarter Biolase reported $13 million in Revenue and -$1.76 earnings per share. This fell short of revenue expectation by $-60,000 and exceeded earnings estimates by $.79.

In the last 3 years, BIOL stock traded as high as $2,348.50 and as low as $.13.

The top ETF exchange traded funds that BIOL belongs to (by Net Assets): VXF.

BIOL has underperformed the market in the last year with a price return of -99.5% while the SPY ETF gained +21.2%. BIOL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -86.5% and -23.5%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

BIOL support price is $.14 and resistance is $.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIOL stock will trade within this expected range on the day.